| Serial Number | 79201837 |
| Word Mark | SLECTRIV |
| Filing Date | Thursday, June 30, 2016 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, January 5, 2024 |
| Registration Number | 5225611 |
| Registration Date | Tuesday, June 20, 2017 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 4, 2017 |
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceutical products; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, January 5, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Novartis AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Event Date | Event Description |
| Friday, January 5, 2024 | CANCELLED SECTION 71 |
| Friday, October 13, 2017 | NOTIFICATION PROCESSED BY IB |
| Friday, July 28, 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, July 28, 2017 | FINAL DISPOSITION PROCESSED |
| Thursday, July 20, 2017 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Tuesday, June 20, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, April 4, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 15, 2017 | NOTICE OF PUBLICATION |
| Tuesday, February 28, 2017 | APPLICATION FILING RECEIPT MAILED |
| Thursday, February 23, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 22, 2017 | ASSIGNED TO EXAMINER |
| Wednesday, February 22, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 17, 2017 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, February 16, 2017 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |